Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of IMBZ18g injection for complicated urinary tract infection including acute pyelonephritis
CTR20261367Phase 2Active
- Sponsor
- Guangzhou H&J New Drug Research
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IMBZ18g in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Guangzhou H&J New Drug Research. Started Apr 2026; status: active.
02
Drugs
IMBZ18g
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20261367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261367.